Therapy for the brain and gut

Journal of Psychiatric Practice

Volumn 11, Issue 1, 2005, Pages 51-53

  Szigethy, Eva ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

ABDOMINAL PAIN; ADOLESCENT; ANAMNESIS; ANXIETY DISORDER; BEHAVIOR THERAPY; BRAIN; CASE REPORT; CHILD PSYCHOLOGY; CLINICAL FEATURE; COGNITIVE THERAPY; CROHN DISEASE; DEPRESSION; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; ENTERITIS; ENVIRONMENT; FAMILY; FEVER; GASTROINTESTINAL DISEASE; HUMAN; INTESTINE; MALE; ONSET AGE; REMISSION; SHORT SURVEY; SOCIAL PSYCHOLOGY; SOMATIZATION;

ADOLESCENT; CHILD; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MENTAL DISORDERS; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS;

EID: 12844285101     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131746-200501000-00007     Document Type: Short Survey

References (15)

1. Hofley P, Piccoli D. Inflammatory bowel disease in children. Med Clin North Am 1994;78:1281-1302.
2. Szigethy EM, Levy-Warren A, Whitton SW, et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: A cross-sectional study. J Pediatr Gastroenterol Nutr 2004;39:395-403.
3. Burke P, Meyer V, Kocoshis S, et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989;28:948-51.
4. Engstrom I. Family interaction and locus of control in children and adolescents with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1991;30:913-20.
5. Gerson MJ, Schonholtz J, Grega CH, et al. The importance of the family context in inflammatory bowel disease. Mt Sinai J Med 1998;65:398-403.
6. King RA. Pediatric inflammatory bowel disease. Child Adolesc Psychiatr Clin N Am 2003;12:537-50.
7. Larson SJ, Dunn AJ. Behavioral effects of cytokines. Brain Behav Immun 2001;15:371-87.
8. Capuron L, Neurauter G, Musselman DL et al. Interferon-alpha-induced changes in tryptophan metabolism: Relationship to depression and paroxetine treatment. Biol Psychiatry 2003;54:906-14.
9. Capuron L, Gumnick JF, Musselman DL, et al. Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropharmacology 2002;26:643-52.
10. Campo JV, Perel J, Lucas A, et al. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: An exploratory study. J Am Acad Child Adolesc Psychiatry 2004;43:1234-42.
11. Szigethy EM, Whitton SW, Levy-Warren A, et al. Cognitive-behavioral therapy for depression in adolescents with inflammatory bowel disease: A pilot study. J Am Acad Child Adolesc Psychiatry 2004;43:1469-77.
12. Weisz J, Thurber C, Sweeney L, et al. Brief treatment of mild-to-moderate child depression using primary and secondary control enhancement training. J Consult Clin Psychol 1997;65:703-7.
13. Rothbaum F, Weisz J, Snyder S. Changing the world and changing the self: A two-process model for perceived control. J Pers Soc Psychol 1982;42:5-37.
14. DeMaso D, Gonzalez-Heydrich J, Dahlmeier Erikson J, et al. The Experience Journal: A computer-based intervention for families facing congenital heart disease. J Am Acad Child Adolesc Psychiatry 2000;39:727-34.
15. Beardslee WR, Gladstone TR, Wright EJ, et al. A family-based approach to the prevention of depressive symptoms in children at risk: Evidence of parental and child change. Pediatrics 2003;112:119-31.